• Explore /
  • Poster
  • / Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.

Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.

Abstract Poster

Authors

null

Jean-Christophe Pignon

Brigham and Women's Hospital, Boston, MA

Jean-Christophe Pignon , Opeyemi Jegede , Christine Horak , Megan Wind-Rotolo , Paul J. Catalano , Jonian Grosha , Abdallah Flaifel , Jesse Novak , Kathleen Margaret Mahoney , Gordon J. Freeman , Arlene Sharpe , Catherine J. Wu , F. Stephen Hodi , Robert J. Motzer , Toni K. Choueiri , Michael B. Atkins , David F. McDermott , Sabina Signoretti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 619)

DOI

10.1200/JCO.2018.36.6_suppl.619

Abstract #

619

Poster Bd #

G12

Abstract Disclosures

Similar Posters

First Author: Miriam Ficial

First Author: Jean-Christophe Pignon

First Author: Nourhan El Ahmar

First Author: Ronan Joseph Kelly